| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322336A1 Method of increasing testosterone and related steroid concentrations in women |
| 07/02/2003 | EP1322311A1 Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist |
| 07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1322305A1 Use of r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature |
| 07/02/2003 | EP1227825A4 Isolation and expansion of human marrow stromal cells |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 07/02/2003 | EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 07/02/2003 | EP0954292B1 Pharmaceutical formulations with delayed drug release |
| 07/02/2003 | EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 07/02/2003 | CN1427727A Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 07/02/2003 | CN1426809A Extenal use ointment for restoring period of knocks and falls |
| 07/02/2003 | CN1426802A Medicine for treating bone disease |
| 07/02/2003 | CN1426794A Chinese medicinal plaster for treating hyperosteogeny |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide |
| 07/01/2003 | US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies |
| 07/01/2003 | US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586432 Neurokinin-1 receptor antagonists |
| 07/01/2003 | US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/01/2003 | US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 07/01/2003 | US6586424 Anticancer agents; anticholesterol agents |
| 07/01/2003 | US6586423 Tyrosine kinase inhibitors |
| 07/01/2003 | US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 07/01/2003 | US6586406 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 07/01/2003 | US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes |
| 07/01/2003 | US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/26/2003 | WO2003052106A1 Method of screening compounds |
| 06/26/2003 | WO2003052091A1 Growth factor modified protein matrices for tissue engineering |
| 06/26/2003 | WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene |
| 06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
| 06/26/2003 | WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 06/26/2003 | WO2003051884A1 Fused indole compound, process for producing the same, and use |
| 06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
| 06/26/2003 | WO2003051868A1 Lactams as tachykinin antagonists |
| 06/26/2003 | WO2003051864A1 Isoflavonoid conjugates, compositions thereof and therapeutic methods involving same |
| 06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
| 06/26/2003 | WO2003051828A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 06/26/2003 | WO2003051825A1 Human adam-10 inhibitors |
| 06/26/2003 | WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents |
| 06/26/2003 | WO2003051403A1 Treatment of osteomyelitis with radiopharmaceuticals |
| 06/26/2003 | WO2003051393A2 Enzymatic cleavable reagents for specific delivery to disease sites |
| 06/26/2003 | WO2003051385A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/26/2003 | WO2003051373A1 Liquid bisphosphonate formulations for bone disorders |
| 06/26/2003 | WO2003051371A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/26/2003 | WO2003051369A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 06/26/2003 | WO2003051365A2 Use of compounds of the benzamide family as immunosuppressant |
| 06/26/2003 | WO2003051361A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation |
| 06/26/2003 | WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/26/2003 | WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 06/26/2003 | WO2003051287A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/26/2003 | WO2003051277A2 Novel compounds |
| 06/26/2003 | WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 06/26/2003 | WO2003020304A3 Inflammation modulatory compound comprising an endomorphin |
| 06/26/2003 | WO2002098352A3 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 06/26/2003 | WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 06/26/2003 | WO2002072079A3 Modulators of the ank-pyrophosphate channel for use in osteoporosis therapy |
| 06/26/2003 | WO2002069971A8 Pharmaceutical compositions and dietary supplements for treatment or improvement of arthitis |
| 06/26/2003 | US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction |
| 06/26/2003 | US20030120059 Cell surface molecule-induced macrophage activation |
| 06/26/2003 | US20030119903 Use of trimebutine for treating pain |
| 06/26/2003 | US20030119902 Novel aminobenzoephenones |
| 06/26/2003 | US20030119896 Chondrogenesis promoters and indolin-2-one derivatives |
| 06/26/2003 | US20030119877 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/26/2003 | US20030119860 Administering to the mammal suffering from non-rheumatoid arthritis a therapeutically effective amount of a secretory phospholiase A2 (sPLA2) inhibitors to treat rheumatoid (an indole compound) |
| 06/26/2003 | US20030119854 Compounds and methods for modulating CXCR3 function |
| 06/26/2003 | US20030119838 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 06/26/2003 | US20030119836 Cyclooxygenase inhibitors |
| 06/26/2003 | US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/26/2003 | US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds |
| 06/26/2003 | US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions |
| 06/26/2003 | US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 06/26/2003 | US20030119820 Substituted indoles |
| 06/26/2003 | US20030119800 Administering an ANGELS (Activators of Non-Genotropic Estrogen-like Signaling compound"ANGELS") compound to maintain or increase bone mass, bone density and/or bone strength. |
| 06/26/2003 | US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors |
| 06/26/2003 | US20030119786 Combinations for the treatment of immunoinflammatory disorders |
| 06/26/2003 | US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury. |
| 06/26/2003 | US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation |
| 06/26/2003 | US20030119111 G-protein coupled receptor, named 2871 receptor |
| 06/26/2003 | US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides |
| 06/26/2003 | US20030119076 B7-like polynucleotides, polypeptides, and antibodies |
| 06/26/2003 | US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use |
| 06/26/2003 | US20030118672 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders |
| 06/26/2003 | US20030118648 Two combined tablet portions, with different releasing rates; drug delivery providing immediate, sustained and prolonged release |
| 06/26/2003 | US20030118638 Oral pharmaceutical products containing 17 beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 06/26/2003 | US20030118634 Administering a bisphosphonate; risedronate, ibandronate, pamidronate, alendronate, cimadronate, tiludronate; osteoporosis |
| 06/26/2003 | US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease |
| 06/26/2003 | US20030118536 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/26/2003 | US20030118508 Treatment of osteomyelitis with radiopharmaceuticals |
| 06/26/2003 | CA2473938A1 Human adam-10 inhibitors |
| 06/26/2003 | CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 06/26/2003 | CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |